publicações selecionadas
-
artigo académico
-
artigo de revista
- WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma. Theranostics. 2018
- Patterns of Microglial Cell Activation in Alzheimer Disease and Frontotemporal Lobar Degeneration. Neurodegenerative Diseases. 2017
- Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas. Oncotarget. 2016
- Does the Interplay between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective. Journal of Alzheimer's Disease. 2016
- Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness. Human Molecular Genetics. 2013
- Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro-Oncology. 2013
- Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer Epidemiology Biomarkers & Prevention. 2011
- Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study. Oncology Reports. 2010
-
documento
- HOXA9-mediated activation of the WNT pathway: functional and clinical relevance in glioblastoma 2015
- Monocarboxylate Transporter 1 (MCT1) expression at hypoxic conditions in glioblastomas: functional role and regulation 2015
- Regulation of Wnt Signaling by HOXA9 in Glioblastoma: Mechanistic and Prognostic Insights 2014
- WNT6 promoter methylation associates with its expression in glioblastoma 2014